219 related articles for article (PubMed ID: 11780699)
1. Role of adjuvant therapy in resected stage II/IIIA non-small-cell lung cancer.
Movsas B
Oncology (Williston Park); 2001 Dec; 15(12):1549-58. PubMed ID: 11780699
[TBL] [Abstract][Full Text] [Related]
2. Role of adjuvant therapy in resected stage II/IIIA non-small-cell lung cancer.
Movsas B
Oncology (Williston Park); 2002 Jan; 16(1):90-5, 100; discussion 100-2, 105-6. PubMed ID: 11831614
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small-cell lung cancer after complete resection. Provincial Lung Cancer Disease Site Group.
Logan DM; Lochrin CA; Darling G; Eady A; Newman TE; Evans WK
Cancer Prev Control; 1997 Dec; 1(5):366-78. PubMed ID: 9765759
[TBL] [Abstract][Full Text] [Related]
4. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
[TBL] [Abstract][Full Text] [Related]
5. Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline.
Pisters KM; Evans WK; Azzoli CG; Kris MG; Smith CA; Desch CE; Somerfield MR; Brouwers MC; Darling G; Ellis PM; Gaspar LE; Pass HI; Spigel DR; Strawn JR; Ung YC; Shepherd FA; ;
J Clin Oncol; 2007 Dec; 25(34):5506-18. PubMed ID: 17954710
[TBL] [Abstract][Full Text] [Related]
6. [Does chemotherapy improve the results of postoperative radiotherapy in completely resected stage II and IIIA non-small-cell bronchial cancer?].
Baumann M
Strahlenther Onkol; 2001 Apr; 177(4):220-1. PubMed ID: 11370558
[No Abstract] [Full Text] [Related]
7. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer.
van Meerbeeck JP; Kramer GW; Van Schil PE; Legrand C; Smit EF; Schramel F; Tjan-Heijnen VC; Biesma B; Debruyne C; van Zandwijk N; Splinter TA; Giaccone G;
J Natl Cancer Inst; 2007 Mar; 99(6):442-50. PubMed ID: 17374834
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy and radiotherapy in the treatment of resectable non-small-cell lung cancer.
Bernstein ED; Herbert SM; Hanna NH
Ann Surg Oncol; 2006 Mar; 13(3):291-301. PubMed ID: 16450219
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant treatment of non-small-cell lung cancer: how do we improve the cure rates further?
Wozniak AJ; Gadgeel SM
Oncology (Williston Park); 2007 Feb; 21(2):163-71; discussion 171, 174, 179-82. PubMed ID: 17396481
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant treatment in resected non-small cell lung cancer: current and future issues.
Remon J; Lianes P; Martínez S; Velasco M; Querol R; Zanui M
Crit Rev Oncol Hematol; 2013 Nov; 88(2):375-86. PubMed ID: 23809199
[TBL] [Abstract][Full Text] [Related]
11. Patient subsets benefiting from adjuvant therapy following surgical resection of non-small cell lung cancer.
Johnson BE; Rabin MS
Clin Cancer Res; 2005 Jul; 11(13 Pt 2):5022s-5026s. PubMed ID: 16000607
[TBL] [Abstract][Full Text] [Related]
12. [Multimodal treatment of non small cell lung cancer].
Stoelben E; Digel W; Henke M; Passlick B
Zentralbl Chir; 2006 Apr; 131(2):110-4. PubMed ID: 16612776
[TBL] [Abstract][Full Text] [Related]
13. Early-stage NSCLC: the role of radiotherapy and systemic therapy.
Bunn PA
J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 2():S31-40. PubMed ID: 19780244
[TBL] [Abstract][Full Text] [Related]
14. Nodal downstaging predicts survival following induction chemotherapy for stage IIIA (N2) non-small cell lung cancer in CALGB protocol #8935.
Jaklitsch MT; Herndon JE; DeCamp MM; Richards WG; Kumar P; Krasna MJ; Green MR; Sugarbaker DJ
J Surg Oncol; 2006 Dec; 94(7):599-606. PubMed ID: 17039491
[TBL] [Abstract][Full Text] [Related]
15. Should aggressive surgery ever be part of the management of small cell lung cancer?
Waddell TK; Shepherd FA
Thorac Surg Clin; 2004 May; 14(2):271-81. PubMed ID: 15382303
[TBL] [Abstract][Full Text] [Related]
16. ACR Appropriateness Criteria® postoperative adjuvant therapy in non-small cell lung cancer.
Decker RH; Langer CJ; Rosenzweig KE; Chang JY; Gewanter RM; Ginsburg ME; Kong FM; Lally BE; Videtic GM; Movsas B
Am J Clin Oncol; 2011 Oct; 34(5):537-44. PubMed ID: 21946673
[TBL] [Abstract][Full Text] [Related]
17. Early-stage non-small-cell lung cancer: current perspectives in combined-modality therapy.
Bunn PA
Clin Lung Cancer; 2004 Sep; 6(2):85-98. PubMed ID: 15476594
[TBL] [Abstract][Full Text] [Related]
18. The role of surgery in N2 non-small cell lung cancer.
DeCamp MM; Ashiku S; Thurer R
Clin Cancer Res; 2005 Jul; 11(13 Pt 2):5033s-5037s. PubMed ID: 16000610
[TBL] [Abstract][Full Text] [Related]
19. Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: focusing on an effect of the number of mediastinal lymph node stations involved.
Matsuguma H; Nakahara R; Ishikawa Y; Suzuki H; Inoue K; Katano S; Yokoi K
Interact Cardiovasc Thorac Surg; 2008 Aug; 7(4):573-7. PubMed ID: 18413349
[TBL] [Abstract][Full Text] [Related]
20. [Early stages of non small cell lung cancer (I. II. IIIA). Postoperative treatments for resected non small-cell lung cancer].
Barlési F
Rev Mal Respir; 2006 Nov; 23(5 Pt 3):16S47-16S53. PubMed ID: 17268336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
